AMTX
BEARISH
$2.29
Live
Aemetis, Inc. · NASDAQ
Target $13.38
(+484.1%)
$1.22
52W Range
$3.66
At a glance
Key valuation, profitability, growth, and risk metrics.
Updated Mar 14, 2026
Market cap
$151.6M
P/E
N/A
ROE
N/A
Profit margin
-39.0%
Debt/Equity
N/A
Dividend yield
N/A
AI Analysis
AI-powered fundamental assessment
Confidence
85%
AMTX exhibits weak financial health with a Piotroski F-Score of 4/9, indicating a fragile operational foundation. The absence of an Altman Z-Score and negative profitability metrics—especially a -38.96% profit margin and -8.96% ROA—signal severe operational distress. Despite a 14.2% YoY revenue growth and recent positive EPS surprises, the company remains unprofitable with negative cash flow and extreme liquidity issues (current ratio of 0.07). The stock trades at a price/sales of 0.77, but this is misleading given the lack of sustainable earnings and deteriorating balance sheet. The 52-week price range of $1.22–$3.66 reflects high volatility and speculative risk.
Key Strengths
14.2% year-over-year revenue growth indicates top-line expansion in a challenging sector
Recent positive EPS surprises (e.g., +62.9% in Q1 2026) suggest potential earnings improvement
Strong recent price momentum (63.6% 1-week return) reflects short-term market optimism
Analyst target price of $13.38 implies significant upside potential if profitability improves
Low price-to-sales ratio (0.77) may indicate undervaluation on a revenue basis
Key Risks
Piotroski F-Score of 4/9 indicates weak financial health and operational instability
Negative profit margin (-38.96%), ROA (-8.96%), and gross margin (-0.39%) reflect deep operational inefficiencies
Extremely weak liquidity: current ratio of 0.07 and quick ratio of 0.01 imply near-term solvency risk
No Altman Z-Score available, but negative profitability and liquidity suggest distress risk
No insider buying activity in 6 months and neutral sentiment (40/100) signal lack of confidence from insiders
Performance Snowflake
Multi-dimensional analysis across 5 key categories
Overall
31
Weak
45
60
30
20
0
AI Verdict
High Risk
Key drivers: Weak Piotroski F-Score (4/9), Negative profitability and liquidity, No Altman Z-Score (distress risk suspected), High volatility and speculative price action, Lack of sustainable earnings despite revenue growth
Confidence
85%
Value
45/100
Ref P/E, PEG, Graham Number
Positives
- Price/Sales of 0.77 is below sector average (avg: ~30.38 P/E, but no direct PS avg)
- Low market cap ($0.15B) may attract speculative investors
- Analyst target price of $13.38 implies 483% upside from current price
Watchpoints
- No Graham Number or intrinsic value due to negative earnings and ROE
- Negative ROA and ROIC suggest poor capital efficiency
- Price/Sales is misleading without earnings sustainability
Future
60/100
Ref Growth rates
Positives
- 14.2% YoY revenue growth aligns with sector average (14.81%)
- Recent EPS growth (77.1% YoY) and Q/Q EPS growth (+78.4%) show improvement
- Positive EPS surprises in recent quarters (e.g., +62.9%) indicate potential earnings recovery
Watchpoints
- No forward P/E or PEG available due to negative earnings
- No free cash flow or operating cash flow data
- Unprofitable business model limits reinvestment and growth sustainability
Past
30/100
Ref Historical trends
Positives
- Historical EPS surprises show volatility but occasional positive beats
- Some quarters show significant upside (e.g., +353.9% in 2023 Q3)
Watchpoints
- Consistently negative earnings over 25 quarters
- Average EPS surprise of -19.36% over last 4 quarters
- Multiple quarters with large negative surprises (e.g., -84.8%, -1080%)
Health
20/100
Ref Altman Z-Score, Piotroski F-Score
Positives
- Piotroski F-Score of 4/9 is not catastrophic but still below stable threshold
Watchpoints
- Piotroski F-Score < 4 indicates weak financial health
- No Altman Z-Score available, but current ratio of 0.07 and quick ratio of 0.01 suggest high default risk
- Negative ROA (-8.96%) and ROIC (N/A) indicate poor capital utilization
- No cash or debt data, but liquidity ratios are alarming
Dividend
0/100
Ref Yield, Payout
Positives
No standout positives identified.
Watchpoints
- No dividend yield or payout ratio
- Dividend strength is 0/100
- Company is unprofitable and cannot sustain dividends
Stock Price & Analyst Targets
Real-time price movements and analyst price targets
Current Price
$2.29
Analyst Target
$13.38
Upside/Downside
+484.1%
Multi-Horizon Performance vs Peers
Price momentum across 5Y → 1W horizons for AMTX and closest competitors.
Updated 2026-03-13
| Company | 5Y | 3Y | 1Y | 6M | 1M | 1W |
|---|---|---|---|---|---|---|
|
AMTX
Aemetis, Inc.
Primary
|
-88.1% | -17.0% | +44.0% | +6.0% | +50.7% | +63.6% |
|
MNTK
Montauk Renewables, Inc.
Peer
|
-88.6% | -83.5% | -42.5% | -44.6% | -15.0% | +0.8% |
|
FRD
Friedman Industries, Incorporated
Peer
|
+127.7% | +62.8% | +27.1% | -13.4% | +2.4% | +4.9% |
|
SMID
Smith-Midland Corporation
Peer
|
+195.5% | +71.4% | +14.8% | -9.9% | +20.0% | +13.8% |
|
FF
FutureFuel Corp.
Peer
|
-33.9% | -8.0% | +8.5% | +1.5% | +12.9% | -2.1% |
AMT
Aemetis, Inc.
Primary
5Y
-88.1%
3Y
-17.0%
1Y
+44.0%
6M
+6.0%
1M
+50.7%
1W
+63.6%
MNT
Montauk Renewables, Inc.
Peer
5Y
-88.6%
3Y
-83.5%
1Y
-42.5%
6M
-44.6%
1M
-15.0%
1W
+0.8%
FRD
Friedman Industries, Incorporated
Peer
5Y
+127.7%
3Y
+62.8%
1Y
+27.1%
6M
-13.4%
1M
+2.4%
1W
+4.9%
SMI
Smith-Midland Corporation
Peer
5Y
+195.5%
3Y
+71.4%
1Y
+14.8%
6M
-9.9%
1M
+20.0%
1W
+13.8%
FF
FutureFuel Corp.
Peer
5Y
-33.9%
3Y
-8.0%
1Y
+8.5%
6M
+1.5%
1M
+12.9%
1W
-2.1%
Positive values indicate cumulative gains over the specified period. Comparables pulled from the same sector to highlight whether momentum is stock-specific or industry-wide.
Historical Performance Trends
Long-term financial metrics and growth patterns
Revenue & Net Income
Profit & Operating Margins
Return on Equity (ROE)
Quarterly Revenue Growth
Historical data shows last 12 quarters (3 years)
Valuation Metrics
Key valuation ratios and pricing indicators
P/E Ratio
N/A
Forward P/E
1.65
PEG Ratio
N/A
P/B Ratio
-0.49
P/S Ratio
0.77
EV/Revenue
2.35
EV/EBITDA
-16.68
Market Cap
$151.6M
Profitability
Profit margins and return metrics
Profit Margin
-38.96%
Operating Margin
-4.62%
Gross Margin
-0.39%
ROE
N/A
ROA
-8.96%
Growth
Revenue and earnings growth rates
Revenue Growth
+14.2%
Earnings Growth
N/A
Q/Q Revenue Growth
N/A
Q/Q Earnings Growth
N/A
Financial Health
Balance sheet strength and liquidity metrics
Debt/Equity
N/A
Current Ratio
0.07
Weak
Quick Ratio
0.01
Poor
Cash/Share
$0.07
Financial Statement Flow
Interactive flow visualization showing how money moves through the company Q3 2025
Revenue
$0.1B
Gross Margin
-0.1%
Op. Margin
-14.4%
Net Margin
-40.1%
Total Assets
$0.2B
Liabilities
$0.5B
Equity
$-0.3B
Debt/Equity
-1.79x
Operating CF
$0.0B
CapEx
$-0.0B
Free Cash Flow
$-0.0B
FCF Yield
-33%
Quarterly Earnings History
EPS performance vs analyst estimates
2026-05-07
$N/A
2026-03-12
$-0.08
+62.9% surprise
2025-11-06
$-0.37
-84.8% surprise
2025-08-07
$-0.41
-36.2% surprise
Basic Materials Sector Comparison
Comparing AMTX against 143 companies in the Basic Materials sector
(14 bullish, 54 neutral, 75 bearish)
Profit Margin
-38.96%
This Stock
vs
-5.75%
Sector Avg
+577.3%
(Superior)
Revenue Growth
14.2%
This Stock
vs
36.56%
Sector Avg
-61.2%
(Slower)
Current Ratio
0.07
This Stock
vs
5.16
Sector Avg
-98.6%
(Weaker)
Similar Companies
Peer comparison within the same industry
| Company | AI Rating | Market Cap | P/E | ROE | Profit Margin | Price | |
|---|---|---|---|---|---|---|---|
|
AMTX
Aemetis, Inc.
|
BEARISH | $151.6M | - | -% | -39.0% | $2.29 | |
|
MNTK
Montauk Renewables, Inc.
|
BEARISH | $170.46M | 119.0 | 0.7% | 1.0% | $1.19 | Compare |
|
FRD
Friedman Industries, Incorporated
|
NEUTRAL | $128.73M | 8.15 | 11.6% | 2.7% | $18.1 | Compare |
|
SMID
Smith-Midland Corporation
|
BULLISH | $180.32M | 14.4 | 26.0% | 13.4% | $33.98 | Compare |
|
FF
FutureFuel Corp.
|
BEARISH | $180.72M | - | -27.4% | -51.6% | $4.12 | Compare |
AMTX
Aemetis, Inc.
BEARISH
Mkt Cap
$152M
P/E
-
ROE
-%
Price
$2.29
Recent Insider Trading
Insider buy and sell transactions from the last 6 months
| Date | Insider | Position | Transaction | Shares | Value |
|---|---|---|---|---|---|
| 2026-01-22 | BARTON FRANCIS P | Director | Stock Award | 18,000 | $27,720 |
| 2026-01-22 | BEEBE LYDIA I | Director | Stock Award | 14,500 | $22,330 |
| 2026-01-22 | BONESS NAOMI LOUISE | Director | Stock Award | 12,000 | $18,480 |
| 2026-01-22 | SIMON TIMOTHY ALAN | Director | Stock Award | 12,000 | $18,480 |
| 2026-01-22 | BLOCK JOHN R | Director | Stock Award | 12,000 | $18,480 |
BARTON FRANCIS P
Director
2026-01-22
18,000 shares
·
$27,720
BEEBE LYDIA I
Director
2026-01-22
14,500 shares
·
$22,330
BONESS NAOMI LOUISE
Director
2026-01-22
12,000 shares
·
$18,480
SIMON TIMOTHY ALAN
Director
2026-01-22
12,000 shares
·
$18,480
BLOCK JOHN R
Director
2026-01-22
12,000 shares
·
$18,480
Insider transactions can signal confidence or concerns about company prospects
Wall Street Analysts
Professional analyst ratings and price targets
Consensus
NONE
4 analysts
Ascendiant Capital
2025-11-19
Buy
Buy
Ascendiant Capital
2025-10-06
Buy
Buy
Past News Coverage
Recent headlines mentioning AMTX from our newsroom.
Newest → oldest
No matching news yet.